Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.12.20.629592

Parallel evolution of LRP2 gene mediating telescope-eye and celestial-eye in goldfish

Abstract

After the intensive artificial selection, the development of celestial-eye in goldfish involves the protuberating and turning upwards of eyeballs, and also degeneration of the retinal. Thus, the celestial-eye goldfish provides an excellent model for both evolutionary and human ocular disease studies. Here, two mapping populations with segregating eye phenotypes in the offspring goldfish were constructed. Though whole genome sequencing using individual samples from the parents and pooled samples from the offspring, and RNA-seq for eyeball samples from pure goldfish lines, a premature stop codon in Exon 38 of LRP2 gene was identified as the top candidate mutation that is responsible for celestial-eye in goldfish. Fatty acid metabolisms and epidermal cells, especially keratocytes related functions were inhibited in the eyeballs of celestial-eye, while inflammatory reactions and extracellular matrix secreting were stimulated. These suggest the dysfunction of cornea in the celestial-eye, and same for retinal, which could be the results of the truncated LRP2 protein. Besides, evidence was provided that not all the goldfish lines share the same causal mutation for celestial-eye, while the same gene LRP2 is in charge of the similar phenotypes (celestial-eye and telescope-eye) in goldfish but no shared mutation. Therefore, those mutations and the associated phenotypes exhibit parallel evolutions in molecular level under artificial selections. Overall, the candidate mutation for celestial-eye in goldfish was identified by this study, and further analyses provide insights into the developmental and evolutionary processes of morphological changes in the eyes of goldfish. Author SummaryAs the first domesticated ornamental fish, goldfish is now worldwide spread and has undergone intensively artificial selections for morphological variations. Among them, celestial-eye is one of the most unique traits for goldfish, which consists of enlarged and protuberant eyes while the eyeballs turning upwards and thus suitable for top viewing in pots. In this study, we have identified that a single nucleotide mutation resulting in disrupted function of LRP2 gene, is responsible for the celestial-eye phenotype. Together with our transcriptome analysis, the genetic and cellular mechanisms for celestial-eye in goldfish were reported for the first time, which provides fundamental knowledge for further studies about the development of eyes in fish and also for ophthalmic diseases in humans. In the aspect of evolution, our study and previous studies reported different truncated LRP2 proteins in charge of celestial-eye and telescope-eye, respectively, which are excellent materials to understand the mechanisms of parallel evolution in molecular level, i.e., independent artificial selections resulting in mutations of the same gene.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Li, R., Zhang, B., Sun, Y., Li, J.. 2024-12-20. Parallel evolution of LRP2 gene mediating telescope-eye and celestial-eye in goldfish. https://doi.org/10.1101/2024.12.20.629592

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Mechanism-selective deep mutational scanning distinguishes ERCC2 disease phenotypes

Pathogenic ERCC2 variants cause xeroderma pigmentosum (XP), trichothiodystrophy (TTD) or both, yet variant effect scores are usually interpreted only as measures of pathogenicity rather than of which disease mechanism is disrupted. XPD, the ERCC2-encoded TFIIH subunit, functions in both nucleotide excision repair and transcription. Using yeast complementation deep mutational scanning, we measured the effects of nearly all XPD amino acid substitutions. The assay was mechanism-selective: it preferentially reported transcription-associated function, with pronounced intolerance at the p44 interface, whereas many substitutions affecting DNA binding and helicase activity retained near-wild-type fitness. Accordingly, TTD variants had much lower fitness than XP variants. Computational predictors discriminated pathogenic from benign variants similarly across phenotypes, but the DMS distinguished XP from TTD variants better than all 73 predictors tested. Phenotype-specific ACMG/AMP calibration provided evidence in both directions for TTD but mainly pathogenic evidence for XP. Thus, the selectivity of functional assays, often viewed as a limitation, can reveal disease mechanisms and support phenotype-aware variant interpretation.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗